BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38720224)

  • 1. Outcome and Factors Related to Isolated Liver Metastasis due to Breast Cancer.
    Sen E; Canbak T; Bostanci O; Battal M
    J Coll Physicians Surg Pak; 2024 May; 34(5):604-609. PubMed ID: 38720224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer].
    Wu SY; Tan Y; Guan YS
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy.
    Rossi V; Nolè F; Redana S; Adamoli L; Martinello R; Aurilio G; Verri E; Sapino A; Viale G; Aglietta M; Montemurro F
    Breast; 2014 Feb; 23(1):44-9. PubMed ID: 24210572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into patterns of first metastatic sites influencing survival of patients with hormone receptor-positive, HER2-negative breast cancer: a multicenter study of 271 patients.
    Yamamura J; Kamigaki S; Fujita J; Osato H; Manabe H; Tanaka Y; Shinzaki W; Hashimoto Y; Komoike Y
    BMC Cancer; 2021 Apr; 21(1):476. PubMed ID: 33926418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver metastases from breast cancer: long-term survival after curative resection.
    Selzner M; Morse MA; Vredenburgh JJ; Meyers WC; Clavien PA
    Surgery; 2000 Apr; 127(4):383-9. PubMed ID: 10776428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Site-Specific Metastases and Surgery in De Novo Stage IV Triple-Negative Breast Cancer: A Population-Based Analysis.
    Gu Y; Wu G; Zou X; Huang P; Yi L
    Med Sci Monit; 2020 Feb; 26():e920432. PubMed ID: 32043484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors for longer disease free survival and overall survival after surgical resection of isolated liver metastasis from breast cancer.
    Zegarac M; Nikolic S; Gavrilovic D; Jevric M; Kolarevic D; Nikolic-Tomasevic Z; Kocic M; Djurisic I; Inic Z; Ilic V; Santrac N
    J BUON; 2013; 18(4):859-65. PubMed ID: 24344009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver resection for breast cancer metastasis: does it improve survival?
    Lubrano J; Roman H; Tarrab S; Resch B; Marpeau L; Scotté M
    Surg Today; 2008; 38(4):293-9. PubMed ID: 18368316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of surgical intervention for isolated breast cancer liver metastasis: Results of case-control study with comparison to medical treatment.
    Wen J; Ye F; Xie F; Liu D; Huang L; Fang C; Zhong S; Ren L
    Cancer Med; 2020 Jul; 9(13):4656-4666. PubMed ID: 32396284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors affecting disease-free survival in patients at age 35 or younger with invasive breast cancer.
    Koca B; Kuru B; Karabicak I; Yürüker SS; Ozen N
    Ann Ital Chir; 2014; 85(3):249-53. PubMed ID: 25074433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates.
    Meloni MF; Andreano A; Laeseke PF; Livraghi T; Sironi S; Lee FT
    Radiology; 2009 Dec; 253(3):861-9. PubMed ID: 19709994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 13. The Clinicopathological Factors Associated with Disease Progression in Luminal A Breast Cancer and Characteristics of Metastasis: A Retrospective Study from A Single Center in China.
    Ye J; Wang W; Xin L; Owen S; Xu L; Duan X; Cheng Y; Zhang H; Zhang S; Li T; Liu Y
    Anticancer Res; 2017 Aug; 37(8):4549-4556. PubMed ID: 28739751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy.
    Onal C; Guler OC; Yildirim BA
    Breast; 2018 Dec; 42():150-156. PubMed ID: 30296648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survival of Patients with Metastatic Recurrent Triple-negative Breast Cancer].
    Peng ZX; Zhong XR; Wang Z; Wang Y; Wang YP; Zheng H; Jing J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):541-546. PubMed ID: 28591958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathological characteristics and prognosis of different molecular types of breast cancer].
    Liu ZF; Chen C; Yao XL; Sun SR
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1733-7. PubMed ID: 27356638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Locoregional recurrence following nipple-sparing mastectomy with immediate breast reconstruction: Patterns and prognostic significance.
    Wu ZY; Han HH; Kim HJ; Lee J; Chung IY; Kim J; Lee S; Han J; Eom JS; Kim SB; Gong G; Kim HH; Son BH; Ahn SH; Ko B
    Eur J Surg Oncol; 2021 Jun; 47(6):1309-1315. PubMed ID: 33495030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
    Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
    Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.